Articoli correlati a Antineoplastic Drugs: Organic Synthesis

Antineoplastic Drugs: Organic Synthesis - Rilegato

 
9781118892541: Antineoplastic Drugs: Organic Synthesis
Vedi tutte le copie di questo ISBN:
 
 
The past decade has seen a significant increase of research aimed at discovering new drugs for treating cancer, and the increasing number of new antineoplastic drugs approved by regulatory agencies reflects this. Until now, details on the synthesis of these newer agents have been scattered in various journals and in US and European patents. This timely volume deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. Compounds are collected in chapters based on the mechanism of action rather than on their chemical structures. Each individual chapter is preceded by a brief description of that mechanism and includes detailed flow charts of the preparation of those compounds accompanied by discussions of the organic chemistry involved in each step. The first half of this volume is dedicated to the syntheses of established chemotherapy drugs. Kinase inhibitors occupy the following chapters with the largest single chapter dealing with the fifty compounds that inhibit tyrosine kinase. This class stands out since over twenty compounds in this group have been approved for treating patients; a rare track record compared to any other class of therapeutic agents. Antineoplastic Drugs: Organic Syntheses is written to appeal to organic and medicinal chemists in industry and academia. It is beneficial to those composing grant proposals for NCI and related organizations. The book is accessible to advanced undergraduates as well as graduates and researchers as well as those with a thorough grasp of organic chemistry.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

  • EditoreJohn Wiley & Sons Inc
  • Data di pubblicazione2015
  • ISBN 10 1118892542
  • ISBN 13 9781118892541
  • RilegaturaCopertina rigida
  • Numero edizione1
  • Numero di pagine213

I migliori risultati di ricerca su AbeBooks

Foto dell'editore

Daniel Lednicer (Analytical Bio-Chemistry Laboratories, Inc., Columbia, Missouri)
Editore: John Wiley and Sons (2015)
ISBN 10: 1118892542 ISBN 13: 9781118892541
Nuovo Rilegato Quantità: > 20
Da:
INDOO
(Avenel, NJ, U.S.A.)
Valutazione libreria

Descrizione libro Condizione: New. Brand New. Codice articolo 1118892542

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 102,19
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,74
In U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

Lednicer, Daniel
Editore: John Wiley & Sons Inc (2015)
ISBN 10: 1118892542 ISBN 13: 9781118892541
Nuovo Rilegato Quantità: 2
Da:
GreatBookPrices
(Columbia, MD, U.S.A.)
Valutazione libreria

Descrizione libro Condizione: New. Codice articolo 20396676-n

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 103,50
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 2,48
In U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

Daniel Lednicer
ISBN 10: 1118892542 ISBN 13: 9781118892541
Nuovo Rilegato Prima edizione Quantità: 1
Da:
Grand Eagle Retail
(Wilmington, DE, U.S.A.)
Valutazione libreria

Descrizione libro Hardcover. Condizione: new. Hardcover. The past decade has seen a significant increase of research aimed at discovering new drugs for treating cancer, and the increasing number of new antineoplastic drugs approved by regulatory agencies reflects this. Until now, details on the synthesis of these newer agents have been scattered in various journals and in US and European patents. This timely volume deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. Compounds are collected in chapters based on the mechanism of action rather than on their chemical structures. Each individual chapter is preceded by a brief description of that mechanism and includes detailed flow charts of the preparation of those compounds accompanied by discussions of the organic chemistry involved in each step. The first half of this volume is dedicated to the syntheses of established chemotherapy drugs. Kinase inhibitors occupy the following chapters with the largest single chapter dealing with the fifty compounds that inhibit tyrosine kinase. This class stands out since over twenty compounds in this group have been approved for treating patients; a rare track record compared to any other class of therapeutic agents. Antineoplastic Drugs: Organic Syntheses is written to appeal to organic and medicinal chemists in industry and academia. It is beneficial to those composing grant proposals for NCI and related organizations. The book is accessible to advanced undergraduates as well as graduates and researchers as well as those with a thorough grasp of organic chemistry. Deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. This volume also focuses on the syntheses of established chemotherapy drugs. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Codice articolo 9781118892541

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 131,80
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

Lednicer, Daniel
Editore: John Wiley & Sons Inc (2015)
ISBN 10: 1118892542 ISBN 13: 9781118892541
Nuovo Rilegato Quantità: 4
Da:
GreatBookPricesUK
(Castle Donington, DERBY, Regno Unito)
Valutazione libreria

Descrizione libro Condizione: New. Codice articolo 20396676-n

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 126,04
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 17,56
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

Daniel Lednicer
Editore: John Wiley & Sons (2015)
ISBN 10: 1118892542 ISBN 13: 9781118892541
Nuovo Rilegato Quantità: 3
Da:
moluna
(Greven, Germania)
Valutazione libreria

Descrizione libro Gebunden. Condizione: New. The past decade has seen a significant increase of research aimed at discovering new drugs for treating cancer, and the increasing number of new antineoplastic drugs approved by regulatory agencies reflects this. Until now, details on the synthesis of these. Codice articolo 556570035

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 94,67
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 48,99
Da: Germania a: U.S.A.
Destinazione, tempi e costi
Foto dell'editore

Lednicer, Daniel
ISBN 10: 1118892542 ISBN 13: 9781118892541
Nuovo Rilegato Prima edizione Quantità: 15
Valutazione libreria

Descrizione libro Condizione: New. Deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. This volume also focuses on the syntheses of established chemotherapy drugs. Num Pages: 232 pages. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational. Dimension: 176 x 252 x 20. Weight in Grams: 506. . 2015. 1st Edition. Hardcover. . . . . Codice articolo V9781118892541

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 140,83
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 10,50
Da: Irlanda a: U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

Daniel Lednicer
ISBN 10: 1118892542 ISBN 13: 9781118892541
Nuovo Rilegato Prima edizione Quantità: 1
Da:
CitiRetail
(Stevenage, Regno Unito)
Valutazione libreria

Descrizione libro Hardcover. Condizione: new. Hardcover. The past decade has seen a significant increase of research aimed at discovering new drugs for treating cancer, and the increasing number of new antineoplastic drugs approved by regulatory agencies reflects this. Until now, details on the synthesis of these newer agents have been scattered in various journals and in US and European patents. This timely volume deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. Compounds are collected in chapters based on the mechanism of action rather than on their chemical structures. Each individual chapter is preceded by a brief description of that mechanism and includes detailed flow charts of the preparation of those compounds accompanied by discussions of the organic chemistry involved in each step. The first half of this volume is dedicated to the syntheses of established chemotherapy drugs. Kinase inhibitors occupy the following chapters with the largest single chapter dealing with the fifty compounds that inhibit tyrosine kinase. This class stands out since over twenty compounds in this group have been approved for treating patients; a rare track record compared to any other class of therapeutic agents. Antineoplastic Drugs: Organic Syntheses is written to appeal to organic and medicinal chemists in industry and academia. It is beneficial to those composing grant proposals for NCI and related organizations. The book is accessible to advanced undergraduates as well as graduates and researchers as well as those with a thorough grasp of organic chemistry. Deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. This volume also focuses on the syntheses of established chemotherapy drugs. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Codice articolo 9781118892541

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 145,31
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 43,32
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi
Foto dell'editore

Lednicer, Daniel
ISBN 10: 1118892542 ISBN 13: 9781118892541
Nuovo Rilegato Quantità: 15
Da:
Kennys Bookstore
(Olney, MD, U.S.A.)
Valutazione libreria

Descrizione libro Condizione: New. Deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. This volume also focuses on the syntheses of established chemotherapy drugs. Num Pages: 232 pages. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational. Dimension: 176 x 252 x 20. Weight in Grams: 506. . 2015. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland. Codice articolo V9781118892541

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 183,21
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 9,84
In U.S.A.
Destinazione, tempi e costi
Immagini fornite dal venditore

Daniel Lednicer
ISBN 10: 1118892542 ISBN 13: 9781118892541
Nuovo Rilegato Prima edizione Quantità: 1
Da:
AussieBookSeller
(Truganina, VIC, Australia)
Valutazione libreria

Descrizione libro Hardcover. Condizione: new. Hardcover. The past decade has seen a significant increase of research aimed at discovering new drugs for treating cancer, and the increasing number of new antineoplastic drugs approved by regulatory agencies reflects this. Until now, details on the synthesis of these newer agents have been scattered in various journals and in US and European patents. This timely volume deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. Compounds are collected in chapters based on the mechanism of action rather than on their chemical structures. Each individual chapter is preceded by a brief description of that mechanism and includes detailed flow charts of the preparation of those compounds accompanied by discussions of the organic chemistry involved in each step. The first half of this volume is dedicated to the syntheses of established chemotherapy drugs. Kinase inhibitors occupy the following chapters with the largest single chapter dealing with the fifty compounds that inhibit tyrosine kinase. This class stands out since over twenty compounds in this group have been approved for treating patients; a rare track record compared to any other class of therapeutic agents. Antineoplastic Drugs: Organic Syntheses is written to appeal to organic and medicinal chemists in industry and academia. It is beneficial to those composing grant proposals for NCI and related organizations. The book is accessible to advanced undergraduates as well as graduates and researchers as well as those with a thorough grasp of organic chemistry. Deals with the organic chemistry involved in the synthesis of the agents found within antineoplastic drugs, including descriptions of the synthetic schemes for the preparation of over 200 compounds that have been granted non-proprietary names. This volume also focuses on the syntheses of established chemotherapy drugs. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Codice articolo 9781118892541

Informazioni sul venditore | Contatta il venditore

Compra nuovo
EUR 167,18
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 34,69
Da: Australia a: U.S.A.
Destinazione, tempi e costi